pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

General characteristics of the study population (combination ≥7 days)

Arrhythmias (n=981) Non-arrhythmias (n=23,259) p-value
Age group (years), n (%)
65-69 213 (21.71) 6,289 (27.04) 0.001*
70-74 268 (27.32) 5,860 (25.19)
≥75 500 (50.97) 11,110 (47.77)
Gender, n (%)
Male 427 (43.53) 10,245 (44.05) 0.745
Female 554 (56.47) 13,014 (55.95)
Type of health coverage, n (%)
Health insurance 827 (84.30) 20,145 (86.61) 0.038*
Medical Aid 154 (15.70) 3,114 (13.39)
Comorbidities, n (%)
CHF 479 (48.83) 3,914 (16.83) <0.001*
COPD 549 (55.96) 11,683 (50.23) <0.001*
CVD 341 (34.76) 6,588 (28.32) <0.001*
DM 504 (51.38) 11,002 (47.30) 0.012*
MI 83 (8.46) 996 (4.28) <0.000*
PVD 352 (35.88) 6,930 (29.79) <0.001*
Cancer 130 (13.25) 3,063 (13.17) 0.940
Cancer Metastasis 18 (1.83) 502 (2.16) 0.493
Dementia 266 (27.12) 5,662 (24.34) 0.050
Mild Liver Disease 353 (35.98) 7,223 (31.05) 0.001*
Moderate or Severe Liver Disease 21 (2.14) 183 (0.79) <0.001*
Plegia 44 (4.49) 916 (3.94) 0.390
PUD 440 (44.85) 9,693 (41.67) 0.048*
Renal Disease 113 (11.52) 1,588 (6.83) <0.001*
Rheumatologic Disease 69 (7.03) 1,522 (6.54) 0.544

CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; CVD: cerebrovascular disease; DM: diabetes mellitus; MI: myocardial infarction; PVD: peripheral vascular disease; PUD: peptic ulcer disease; *p<0.05

Korean J Clin Pharm 2023;33:242-53 https://doi.org/10.24304/kjcp.2023.33.4.242
© 2023 Korean J Clin Pharm